Santen Pharmaceutical (SNPHY) News Today $10.30 -0.06 (-0.58%) As of 03:44 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartSEC FilingsShort InterestBuy This Stock SNPHY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Santen Pharmaceutical Reports Progress on Share Buyback InitiativeOctober 1, 2025 | tipranks.comSanten Pharmaceutical Updates on Share Buyback ProgressSeptember 1, 2025 | tipranks.comSanten and RemeGen sign licence deal for retinal disease injectionAugust 19, 2025 | msn.comSanten Pharmaceutical Co (SNPHY) - Investing.com UKAugust 8, 2025 | uk.investing.comSanten Pharmaceutical Updates on Share Buyback ProgressJuly 1, 2025 | tipranks.comSanten Pharmaceutical FY Net Y36.26B Vs Net Y26.64BMay 13, 2025 | marketwatch.comChina’s NMPA authorises Santen’s glaucoma treatment applicationApril 7, 2025 | msn.comSanten Pharmaceutical to Cancel 5 Million Treasury SharesFebruary 6, 2025 | tipranks.comSanten Pharmaceutical Co. Revises Year-End Dividend ForecastFebruary 6, 2025 | tipranks.comSanten Pharmaceutical Announces Share Buyback PlanNovember 8, 2024 | markets.businessinsider.comSanten Pharmaceutical Co., Ltd. GAAP EPS of Yen 27.85, revenue of Yen 72.34BAugust 6, 2024 | msn.comHere's what to expect from Santen Pharmaceutical's earnings reportAugust 6, 2024 | markets.businessinsider.comSNPHY Stock Earnings: Santen Pharmaceutical Reported Results for Q4 2023May 17, 2024 | investorplace.comSanten Pharmaceutical earnings preview: what to expectMay 9, 2024 | markets.businessinsider.comSanten Pharmaceutical Co LtdApril 23, 2024 | morningstar.comMSanten Pharmaceutical Co. Ltd. ADRApril 20, 2024 | wsj.comSanten Pharmaceutical Co. Ltd. (JP3336000009.SG)December 27, 2023 | finance.yahoo.comSanten Pharmaceutical Co. - ADR (SNPHY) Price Target Increased by 7.52% to 10.41October 4, 2023 | msn.comSNPHY Santen Pharmaceutical Co., Ltd.August 9, 2023 | seekingalpha.comSanten Pharmaceutical Co., Ltd. reports Q1 resultsAugust 4, 2023 | msn.comHarrow Acquires Santen's Branded Ophthalmic PortfolioJuly 19, 2023 | benzinga.comSanten Agrees to Licensing Agreements and Asset Transfer for its Pharmaceutical Products in North AmericaJuly 19, 2023 | businesswire.comSanten Pharmaceutical Co. reports FY resultsMay 11, 2023 | msn.comSanten Pharmaceutical is about to announce its earnings — here's what to expectAugust 4, 2022 | markets.businessinsider.comOphthalmology Equipment Market Demand Analysis & Opportunity Outlook 2029July 23, 2022 | marketwatch.comOphthalmology Equipment Market Demand, Opportunity, Outlook, Trends, Revenue, Future Growth Opportunities By2029May 24, 2022 | marketwatch.comSanten Pharmaceutical Co (SNPHY)December 2, 2021 | investing.comSanten Pharmaceutical Co., Ltd. 2021 Q2 - Results - Earnings Call PresentationNovember 11, 2021 | seekingalpha.com Get Santen Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for SNPHY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SNPHY Media Mentions By Week SNPHY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNPHY News Sentiment▼0.000.75▲Average Medical News Sentiment SNPHY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNPHY Articles This Week▼00▲SNPHY Articles Average Week Get the Latest News and Ratings for SNPHY and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Santen Pharmaceutical and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AZNCF News CMOPF News CSPCY News JCRRF News KYKOF News MAYNF News OPHLY News OTSKF News RHHVF News SNYNF News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SNPHY) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredWhy Wall Street is piling into the “Debasement Trade”Wall Street is piling into what insiders are calling the “Debasement Trade” — and according to former Goldman ...Stansberry Research | Sponsored2 Nobel Prize winners warn of once-in-a-generation wealth shift…An unstoppable force is reshaping America — one so powerful it’s already disrupting how we work, invest, and l...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Santen Pharmaceutical Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Santen Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
